Elanco Animal Health Stock Forecast
NYSE: ELANHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 9:47 AM ET
ELAN analyst consensus
Consensus (16 analysts)
strong_buy
Avg. price target
$31.00+37.41%
- Strong buy 4
- Buy 10
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 16 Wall Street analysts covering Elanco Animal Health (2026-10-07), 14 rate the stock a buy or strong buy, 2 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $31.00, with a high estimate of $34.00 and a low estimate of $26.00. The average target implies upside of 37.4% from the current price of $22.56.
The spread between the highest and lowest targets is 30.8%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ELAN.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 4 | 25% |
| Buy | 10 | 63% |
| Hold | 2 | 13% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $26.00 | +15.25% |
| Average target | $31.00 | +37.41% |
| High target | $34.00 | +50.71% |